DRAFT FOR APPROVAL
... function tests before initiation of treatment, during each cycle of treatment, and as clinically indicated. ...
... function tests before initiation of treatment, during each cycle of treatment, and as clinically indicated. ...
Lycopene and Soy Isoflavones in the Treatment of Prostate Cancer
... Phase II clinical trial in prostate cancer patients, we observed prostate-specific antigen (PSA) stabilization with soy isoflavone intake. In this Phase II clinical trial, we investigated the efficacy of lycopene alone or in combination with soy isoflavones on serum PSA levels in men with prostate c ...
... Phase II clinical trial in prostate cancer patients, we observed prostate-specific antigen (PSA) stabilization with soy isoflavone intake. In this Phase II clinical trial, we investigated the efficacy of lycopene alone or in combination with soy isoflavones on serum PSA levels in men with prostate c ...
The index lesion and focal therapy: an analysis of
... insignificant disease are not likely to benefit from curative therapy and, as a result, will only experience harm if subjected to treatment. However, the definition of clinically significant disease has not been agreed. There are many definitions, most of which represent a small departure from that ...
... insignificant disease are not likely to benefit from curative therapy and, as a result, will only experience harm if subjected to treatment. However, the definition of clinically significant disease has not been agreed. There are many definitions, most of which represent a small departure from that ...
Informed Decision-making for Prostate Cancer Testing
... Beyond the mortality figures, however, prostate cancer is also associated with considerable morbidity, particularly in advanced stages, which may be associated with difficulties with urination, significant fatigue, kidney failure, and bone pain.4 Interventions for prostate cancer can also be associa ...
... Beyond the mortality figures, however, prostate cancer is also associated with considerable morbidity, particularly in advanced stages, which may be associated with difficulties with urination, significant fatigue, kidney failure, and bone pain.4 Interventions for prostate cancer can also be associa ...
Update in outpatient internal medicine
... risk, baseline health and option for delayed curative treatment Collaboration with urology community to determine treatment options is essential ...
... risk, baseline health and option for delayed curative treatment Collaboration with urology community to determine treatment options is essential ...
Second Primary Cancer
... in our cohort as compared to rates of cancer in the West of Scotland general population. - Non melanoma skin neoplasms and smoking related neoplasms were the most common cancers. ...
... in our cohort as compared to rates of cancer in the West of Scotland general population. - Non melanoma skin neoplasms and smoking related neoplasms were the most common cancers. ...
Cancer – the Essentials
... A 70-year old male with advanced hormonerefractory prostate cancer presents with multifocal pain, especially in hiss back. He has been treated by bilateral orchiectomy and radiotherapy to the hemipelvis. His PSA is 100 ng/mL, and a recent ...
... A 70-year old male with advanced hormonerefractory prostate cancer presents with multifocal pain, especially in hiss back. He has been treated by bilateral orchiectomy and radiotherapy to the hemipelvis. His PSA is 100 ng/mL, and a recent ...
Cancer Screening Factsheet - UNON Joint Medical Service
... colon or rectal cancer or colon problems that raise risk. Screening tests can often find growths called polyps, which can be removed before they turn into cancer. These tests also can find colon and rectal cancer earlier, when treatments are more likely to be successful. ...
... colon or rectal cancer or colon problems that raise risk. Screening tests can often find growths called polyps, which can be removed before they turn into cancer. These tests also can find colon and rectal cancer earlier, when treatments are more likely to be successful. ...
Percent-free prostate specific antigen is elevated in men on
... All subjects receiving treatment by chronic haemodialysis with low-flux membranes or CAPD at our dialysis unit between January 1999 and September 2001 were considered for inclusion in this study. We excluded one patient on haemodialysis and four patients on CAPD with a diagnosis of prostate cancer, ...
... All subjects receiving treatment by chronic haemodialysis with low-flux membranes or CAPD at our dialysis unit between January 1999 and September 2001 were considered for inclusion in this study. We excluded one patient on haemodialysis and four patients on CAPD with a diagnosis of prostate cancer, ...
BCCA Protocol Summary for Palliative Therapy
... Bilirubin less than ULN, AST/ALT less than 5 x ULN, Alkaline Phosphatase less than 6 x ULN Disease that is not amenable to radiation therapy and where an objective disease response is deemed crucial to improve symptoms (e.g. bulky lymph node disease) For other indications, or for more than 10 ...
... Bilirubin less than ULN, AST/ALT less than 5 x ULN, Alkaline Phosphatase less than 6 x ULN Disease that is not amenable to radiation therapy and where an objective disease response is deemed crucial to improve symptoms (e.g. bulky lymph node disease) For other indications, or for more than 10 ...
Hope Light “Cancer Corner” - Indiana Rural Health Association
... Cancer Corner publications are provided at no cost to visitors. The publications consist of brochures, booklets, pamphlets and DVDs/CDs on all-cancers topics to include; cancer prevention; cancer signs and symptoms, screening tests, self-exams, clinical trials and treatments; diet and nutrition info ...
... Cancer Corner publications are provided at no cost to visitors. The publications consist of brochures, booklets, pamphlets and DVDs/CDs on all-cancers topics to include; cancer prevention; cancer signs and symptoms, screening tests, self-exams, clinical trials and treatments; diet and nutrition info ...
Ontario`s top cancers different from those
... stomach cancer is less common and cervical cancer is the 12 th most common cancer among Ontario women. Although liver cancer is uncommon in Ontario, with approximately 200 cases diagnosed a year, rates are increasing quickly, especially in men. This rise is thought to be tied to alcohol abuse, obesi ...
... stomach cancer is less common and cervical cancer is the 12 th most common cancer among Ontario women. Although liver cancer is uncommon in Ontario, with approximately 200 cases diagnosed a year, rates are increasing quickly, especially in men. This rise is thought to be tied to alcohol abuse, obesi ...
IPG118 High-intensity focused ultrasound for prostate cancer
... another study. In a small number of men, an abnormal connection called a fistula was made between the rectum and the urethra (which carries the urine down to the penis) – this happened in less than 1% (1 man out of 137) in one study, and 3% (3 out of 111 men) in another study. Impotence (the failure ...
... another study. In a small number of men, an abnormal connection called a fistula was made between the rectum and the urethra (which carries the urine down to the penis) – this happened in less than 1% (1 man out of 137) in one study, and 3% (3 out of 111 men) in another study. Impotence (the failure ...
here - Kingstone Surgery
... or pain, and can lead to death. For most of these cancers there is some form of treatment available such as surgery, chemotherapy or radiotherapy. The commonsense view is that it is a good idea to find these cancers as early as possible so that they can be treated and hopefully cured before they bec ...
... or pain, and can lead to death. For most of these cancers there is some form of treatment available such as surgery, chemotherapy or radiotherapy. The commonsense view is that it is a good idea to find these cancers as early as possible so that they can be treated and hopefully cured before they bec ...
trends in Prostate cancer survival in switzerland
... relative survival of prostate cancer patients in Europe are the result of PSA screening, leading to earlier diagnosis, lead-time bias, and over-diagnosis, (i.e. more frequent diagnosis of low-stage and also low-risk tumors) [15]. In some countries, such as England, the effect has also been reported ...
... relative survival of prostate cancer patients in Europe are the result of PSA screening, leading to earlier diagnosis, lead-time bias, and over-diagnosis, (i.e. more frequent diagnosis of low-stage and also low-risk tumors) [15]. In some countries, such as England, the effect has also been reported ...
The New Biology of Prostate Cancer
... This activity has been designed to meet the educational needs of medical and radiation oncologists, urologists and other allied healthcare providers involved in the research and treatment of prostate cancer (PC). OVERVIEW OF ACTIVITY Cancer of the genitourinary system affects hundreds of thousands o ...
... This activity has been designed to meet the educational needs of medical and radiation oncologists, urologists and other allied healthcare providers involved in the research and treatment of prostate cancer (PC). OVERVIEW OF ACTIVITY Cancer of the genitourinary system affects hundreds of thousands o ...
prostate brachytherapy
... five years ago will survive prostate cancer. For men diagnosed and treated 10 years ago, 91% will survive. If you have just recently been diagnosed, the outlook is most likely much better, due to earlier detection and improvements in treatment. Your doctor has suggested a treatment called Brachyther ...
... five years ago will survive prostate cancer. For men diagnosed and treated 10 years ago, 91% will survive. If you have just recently been diagnosed, the outlook is most likely much better, due to earlier detection and improvements in treatment. Your doctor has suggested a treatment called Brachyther ...
View or save the full text Mini Review as a file
... toxicity of DES. Because the VACURG results showed a 36% increase in mortality in the 5-mg arm, he was looking for the ideal dose that would demonstrate efficacy while limiting its cardiovascular toxicity [2]. Hypercoagulability has been linked to the increased synthesis of the coagulation factors I ...
... toxicity of DES. Because the VACURG results showed a 36% increase in mortality in the 5-mg arm, he was looking for the ideal dose that would demonstrate efficacy while limiting its cardiovascular toxicity [2]. Hypercoagulability has been linked to the increased synthesis of the coagulation factors I ...
Jevtana® Improves Survival in Advanced Prostate Cancer
... The data demonstrated that Jevtana® in combination with prednisone reduced the risk of death by 30% in men with metastatic castration-resistant prostate cancer (also known as metastatic hormone refractory prostate cancer, or mHRPC) whose disease progressed following treatment with docetaxel-based ch ...
... The data demonstrated that Jevtana® in combination with prednisone reduced the risk of death by 30% in men with metastatic castration-resistant prostate cancer (also known as metastatic hormone refractory prostate cancer, or mHRPC) whose disease progressed following treatment with docetaxel-based ch ...
Sample press release about oral cancer and your screening event
... US. It kills one person every hour of every day, and approximately 132 new individuals will be diagnosed with it each day. The good news is that it can often be found early in its development, through a simple, painless, and quick screening. Who should get screened? Every adult. Oral cancer can ofte ...
... US. It kills one person every hour of every day, and approximately 132 new individuals will be diagnosed with it each day. The good news is that it can often be found early in its development, through a simple, painless, and quick screening. Who should get screened? Every adult. Oral cancer can ofte ...
